1. Home
  2. TUSK vs VXRT Comparison

TUSK vs VXRT Comparison

Compare TUSK & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUSK
  • VXRT
  • Stock Information
  • Founded
  • TUSK 2014
  • VXRT N/A
  • Country
  • TUSK United States
  • VXRT United States
  • Employees
  • TUSK N/A
  • VXRT N/A
  • Industry
  • TUSK Oilfield Services/Equipment
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TUSK Energy
  • VXRT Health Care
  • Exchange
  • TUSK Nasdaq
  • VXRT Nasdaq
  • Market Cap
  • TUSK 128.0M
  • VXRT 119.0M
  • IPO Year
  • TUSK 2016
  • VXRT N/A
  • Fundamental
  • Price
  • TUSK $2.63
  • VXRT $0.34
  • Analyst Decision
  • TUSK
  • VXRT Strong Buy
  • Analyst Count
  • TUSK 0
  • VXRT 2
  • Target Price
  • TUSK N/A
  • VXRT $3.00
  • AVG Volume (30 Days)
  • TUSK 270.8K
  • VXRT 2.0M
  • Earning Date
  • TUSK 05-01-2025
  • VXRT 05-12-2025
  • Dividend Yield
  • TUSK N/A
  • VXRT N/A
  • EPS Growth
  • TUSK N/A
  • VXRT N/A
  • EPS
  • TUSK N/A
  • VXRT N/A
  • Revenue
  • TUSK $187,932,000.00
  • VXRT $28,700,000.00
  • Revenue This Year
  • TUSK N/A
  • VXRT N/A
  • Revenue Next Year
  • TUSK $28.22
  • VXRT N/A
  • P/E Ratio
  • TUSK N/A
  • VXRT N/A
  • Revenue Growth
  • TUSK N/A
  • VXRT 288.94
  • 52 Week Low
  • TUSK $1.68
  • VXRT $0.28
  • 52 Week High
  • TUSK $4.94
  • VXRT $1.07
  • Technical
  • Relative Strength Index (RSI)
  • TUSK 61.95
  • VXRT 35.97
  • Support Level
  • TUSK $1.85
  • VXRT $0.28
  • Resistance Level
  • TUSK $2.64
  • VXRT $0.38
  • Average True Range (ATR)
  • TUSK 0.30
  • VXRT 0.04
  • MACD
  • TUSK 0.09
  • VXRT 0.01
  • Stochastic Oscillator
  • TUSK 89.62
  • VXRT 40.00

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: